A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis

BACKGROUND: Antiepidermal growth factor receptor (EGFR)-targeted therapy is widely used in many epithelial cancer types. We investigated lapatinib effects on cutaneous squamous cell carcinoma (cSCC) scheduled for resection and in coexisting precursor lesions (actinic keratosis (AK) and Bowen's...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:ESMO Open
Prif Awduron: Jenni, D, Karpova, MB, Mühleisen, B, Mangana, J, Dreier, J, Hafner, J, Dummer, R
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070204/
https://ncbi.nlm.nih.gov/pubmed/27843579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2015-000003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg